David M. Berman, HEAD OF R&D at Immunocore Holdings plc (IMCR), sold 43,964 shares at $35.63 ($1.6M) on 2025-09-12, disclosed to the SEC on 2025-09-16.
Scheduled sale ($1.6M) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.63 | 21,232 | $756K | 48.3% |
| 2 | $35.63 | 21,232 | $756K | 48.3% |
| 3 | $36.31 | 1,300 | $47K | 3.0% |
| 4 | $35.01 | 200 | $7K | 0.4% |
| Total | $35.65 avg | 43,964 | $1.6M | 100% |
| Filing → |
| IMCR | SELL | 2025-12-01 | $6.0M | — | Filing → |
| IMCR | SELL | 2025-11-26 | $1.4M | — | Filing → |
| IMCR | SELL | 2025-10-02 | $4.4M | — | Filing → |